19th Jun 2007 07:03
AstraZeneca PLC19 June 2007 (NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO ORFROM AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULDCONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION) AstraZeneca Successfully Completes Acquisition of MedImmune AstraZeneca PLC ("AstraZeneca") today announced that on June 18, 2007 itcompleted its acquisition of MedImmune, Inc. ("MedImmune") pursuant to ashort-form merger in which a subsidiary of AstraZeneca was merged with and intoMedImmune with MedImmune continuing as the surviving corporation. MedImmune isaccordingly now 100% owned by AstraZeneca. AstraZeneca had previously announcedthe acquisition of approximately 91.6% of MedImmune's outstanding common stockpursuant to a cash tender offer. In connection with the merger, all remainingoutstanding shares of MedImmune's common stock (other than any shares in respectof which appraisal rights are validly exercised under Delaware law and anyshares owned by MedImmune, AstraZeneca or any of their subsidiaries), wereconverted into the right to receive the same $58.00 cash per share, withoutinterest, that was paid in the tender offer. -Ends- June 19 2007 AstraZeneca Media Enquiries:Steve Brown / Edel McCaffrey (London) (020) 7304 5033/5034Staffan Ternby (Sweden) (8) 553 26107Emily Denney (Wilmington) (302) 885 3451 Analyst/Investor Enquiries:Jonathan Hunt / Mina Blair / Karl Hard (London) (020) 7304 5087/5084/5322Staffan Ternby (Sweden) (8) 553 26107Ed Seage / Jorgen Winroth (US) (302) 886 4065/(212) 579 0506 Merrill Lynch (Financial Adviser to AstraZeneca) +44 (0) 20 7628 1000Richard Girling Deutsche Bank (Joint Corporate Broker to AstraZeneca) +44 (0) 20 7545 8000Charlie Foreman Goldman Sachs (Joint Corporate Broker to AstraZeneca) +44 (0) 20 7774 1000Phil Raper MedImmune Media Enquiries:Jamie Lacey 301-398-4035 Analyst/Investor Enquiries:Pete Vozzo 301-398-4358 Not for release, publication or distribution, in whole or in part, in, into orfrom Australia, Canada or Japan This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca